Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Refractory Peripheral T-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01435863
What this trial is testing

SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
Solasia Pharma K.K. 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07288814
What this trial is testing

Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T Cell Lymphoma
Sun Yat-Sen University Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT06925464
What this trial is testing

CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT01378871
What this trial is testing

A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

Who this might be right for
Adult T Cell LeukemiaAdult T Cell Lymphoma
Amit Verma 1
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Early research (Phase 1)UnknownNCT04108325
What this trial is testing

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-Cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT00364923
What this trial is testing

Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Acrotech Biopharma Inc. 115
Testing effectiveness (Phase 2)UnknownNCT03107962
What this trial is testing

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Mingzhi Zhang 20
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Not Yet RecruitingNCT07842445
What this trial is testing

Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.

Who this might be right for
Solid Tumor (Phase I)Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Great Novel Therapeutics Biotech & Medicals Corporation 70
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT04917250
What this trial is testing

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
Beijing Tongren Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06733051
What this trial is testing

Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)

Who this might be right for
Natural Killer T-cell Lymphoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT05941156
What this trial is testing

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

Who this might be right for
Extranodal NK T Cell LymphomaNK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)Temporarily pausedNCT04828174
What this trial is testing

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Who this might be right for
Peripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)UnknownNCT04705090
What this trial is testing

YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
PTCL
Shanghai YingLi Pharmaceutical Co. Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07791615
What this trial is testing

A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma

Who this might be right for
LymphomaNK T-Cell Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)UnknownNCT05179213
What this trial is testing

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06966154
What this trial is testing

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Who this might be right for
Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL
Fudan University 68
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Next Page